Biomarker predicts KRASG12C inhibitor success in lung cancer treatment
A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies. The research, published in Clinical Cancer ...
American Cancer Society12h
How Telehealth Visits Can Help Support You During Cancer
A recent study published in JAMA explored whether getting telehealth visits, rather than in-person visits, affects the ...
The American Journal of Managed Care12h
5 Potential Therapeutic Targets for Small Cell Lung Cancer
According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...
Targeted Oncology13h
Tailoring CDS Tool Improves Biomarker Documentation in Cancer Treatment
Daniel Rubin, PharmD, BCOP, discussed a study showing how a clinical decision support tool can improve the documentation of ...
Healio14h
Survival better with lobectomy vs. wedge resection in early stage lung cancer
Among patients with stage IA non-small cell lung cancer, long-term survival was better with lobectomy or segmentectomy vs. wedge resection, according to results presented at the Society of Thoracic ...
Frontiers18h
Exploring the Tumor Microenvironment in Resectable Lung Cancer
Lung cancer treatment and outcomes are profoundly influenced by the tumor microenvironment (TME), particularly in resectable ...
T-cell analysis reveals potential for personalized liver cancer immunotherapy
T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...